کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
2040447 | 1073111 | 2015 | 11 صفحه PDF | دانلود رایگان |

• L-DOPA augments D2-receptor-mediated synaptic transmission in the midbrain
• Serotonin terminals contribute to dopamine synaptic transmission after L-DOPA
• L-DOPA depresses 5-HT-mediated synaptic transmission in the dorsal raphe
• In the dorsal raphe, serotonin neurons release dopamine from vesicles after L-DOPA
SummaryImbalance between the dopamine and serotonin (5-HT) neurotransmitter systems has been implicated in the comorbidity of Parkinson’s disease (PD) and psychiatric disorders. L-DOPA, the leading treatment of PD, facilitates the production and release of dopamine. This study assessed the action of L-DOPA on monoamine synaptic transmission in mouse brain slices. Application of L-DOPA augmented the D2-receptor-mediated inhibitory postsynaptic current (IPSC) in dopamine neurons of the substantia nigra. This augmentation was largely due to dopamine release from 5-HT terminals. Selective optogenetic stimulation of 5-HT terminals evoked dopamine release, producing D2-receptor-mediated IPSCs following treatment with L-DOPA. In the dorsal raphe, L-DOPA produced a long-lasting depression of the 5-HT1A-receptor-mediated IPSC in 5-HT neurons. When D2 receptors were expressed in the dorsal raphe, application of L-DOPA resulted in a D2-receptor-mediated IPSC. Thus, treatment with L-DOPA caused ectopic dopamine release from 5-HT terminals and a loss of 5-HT-mediated synaptic transmission.
Graphical AbstractFigure optionsDownload as PowerPoint slide
Journal: - Volume 12, Issue 6, 11 August 2015, Pages 944–954